Cargando…

Case report: Methylphenidate improved chronic pain in an adult patient with attention deficit hyperactivity disorder

INTRODUCTION: Chronic pain remains a health problem that is difficult to treat adequately. Its unknown cause and complex comorbidity with other illnesses, including mental disorders, amplify the severity of symptoms, which consequently decreases the quality of life of patients long term. In our clin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zain, Ekachaeryanti, Sugimoto, Atsunori, Egawa, Jun, Someya, Toshiyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10038200/ https://www.ncbi.nlm.nih.gov/pubmed/36970292 http://dx.doi.org/10.3389/fpsyt.2023.1091399

Ejemplares similares

New Insights on the Effects of Methylphenidate in Attention Deficit Hyperactivity Disorder
por: Pitzianti, Maria Bernarda, et al.
Publicado: (2020)

Methylphenidate for Attention-Deficit and Hyperactivity Disorder in Adult Patients With Substance Use Disorders: Good Clinical Practice
por: Chamakalayil, Sunsha, et al.
Publicado: (2021)

Continuity in Methylphenidate Treatment of Adults With Attention-Deficit/Hyperactivity Disorder
por: Olfson, Mark, et al.
Publicado: (2007)

Methylphenidate use in children with attention deficit hyperactivity disorder
por: Machado, Felipe Salles Neves, et al.
Publicado: (2015)

Case report: Atomoxetine improves chronic pain with comorbid post-traumatic stress disorder and attention deficit hyperactivity disorder
por: Kasahara, Satoshi, et al.
Publicado: (2023)

The three-factor structure of the Autism-Spectrum Quotient Japanese version in pregnant women
por: Zain, Ekachaeryanti, et al.
Publicado: (2023)

The effect of methylphenidate on pain perception thresholds in children with attention deficit hyperactivity disorder
por: Bozkurt, Abdullah, et al.
Publicado: (2023)

In silico clinical trial evaluating lisdexamfetamine’s and methylphenidate’s mechanism of action computational models in an attention-deficit/hyperactivity disorder virtual patients’ population
por: Gutiérrez-Casares, José Ramón, et al.
Publicado: (2023)

The lowest effective plasma concentration of atomoxetine in pediatric patients with attention deficit/hyperactivity disorder: A non-randomized prospective interventional study
por: Sugimoto, Atsunori, et al.
Publicado: (2021)

Viloxazine in the Treatment of Attention Deficit Hyperactivity Disorder
por: Edinoff, Amber N., et al.
Publicado: (2021)

Management of attention-deficit hyperactivity disorder in adults: focus on methylphenidate hydrochloride
por: Nair, Rajasree, et al.
Publicado: (2009)

The Safety and Efficacy of Methylphenidate and Dexmethylphenidate in Adults with Attention Deficit/Hyperactivity Disorder
por: Sopko, Michael A., et al.
Publicado: (2010)

Methylphenidate for attention-deficit/hyperactivity disorder in adults: a narrative review
por: Jaeschke, Rafał R., et al.
Publicado: (2021)

The Effects of Methylphenidate on Decision Making in Attention-Deficit/Hyperactivity Disorder
por: DeVito, Elise E., et al.
Publicado: (2008)

The Effect of Methylphenidate on the Hearing of Children with Attention Deficit Hyperactivity Disorder
por: İsmi, Onur, et al.
Publicado: (2018)

The Association Between Attention-Deficit Hyperactivity Disorder, Injuries, and Methylphenidate
por: Shem-Tov, Sharon, et al.
Publicado: (2019)

Individualizing the dosage of Methylphenidate in children with attention deficit hyperactivity disorder
por: Shirafkan, Hoda, et al.
Publicado: (2020)

Shifting uncertainty intolerance: methylphenidate and attention-deficit hyperactivity disorder
por: Mandali, Alekhya, et al.
Publicado: (2021)

Pica in an Adolescent with Attention Deficit Hyperactivity Disorder responsive to Methylphenidate
por: Bourgou, Soumaya, et al.
Publicado: (2021)

Tackling emotional processing in adults with attention deficit hyperactivity disorder and attention deficit hyperactivity disorder + autism spectrum disorder using emotional and action verbal fluency tasks
por: Walter, Amélia, et al.
Publicado: (2023)

Attention Deficit Hyperactivity Disorder: Association With Obesity and Eating Disorders
por: Ravi, Prithvi, et al.
Publicado: (2020)

Why the Diagnosis of Attention Deficit Hyperactivity Disorder Matters
por: Hamed, Alaa M., et al.
Publicado: (2015)

Attention Deficit Hyperactivity Disorder in the Light of the Epigenetic Paradigm
por: Schuch, Viviane, et al.
Publicado: (2015)

Epigenetics and Attention-Deficit/Hyperactivity Disorder: New Perspectives?
por: Mirkovic, Bojan, et al.
Publicado: (2020)

Comparison of the effects of methylphenidate and the combination of methylphenidate and risperidone in preschool children with attention-deficit hyperactivity disorder
por: Safavi, Parvin, et al.
Publicado: (2016)

Neural Correlates of Reactive Aggression in Adult Attention-Deficit/Hyperactivity Disorder
por: Jakobi, Babette, et al.
Publicado: (2022)

Transdermal Therapy for Attention-Deficit Hyperactivity Disorder with the Methylphenidate Patch (MTS)
por: Findling, Robert L., et al.
Publicado: (2014)

Integrative genomic analysis of methylphenidate response in attention-deficit/hyperactivity disorder
por: Pagerols, Mireia, et al.
Publicado: (2018)

Does Methylphenidate Work in Children and Adolescents with Attention Deficit Hyperactivity Disorder?
por: Pereira Ribeiro, Johanne, et al.
Publicado: (2021)

Neural Markers of Methylphenidate Response in Children With Attention Deficit Hyperactivity Disorder
por: Arnett, Anne B., et al.
Publicado: (2022)

Treatment with Methylphenidate Improves Affective but Not Cognitive Empathy in Youths with Attention-Deficit/Hyperactivity Disorder
por: Fantozzi, Pamela, et al.
Publicado: (2021)

Gray Matter Network Associated With Attention in Children With Attention Deficit Hyperactivity Disorder
por: Wang, Xing-Ke, et al.
Publicado: (2022)

Low serum sphingolipids in children with attention deficit-hyperactivity disorder
por: Henríquez-Henríquez, Marcela P., et al.
Publicado: (2015)

Alterations of Growth Factors in Autism and Attention-Deficit/Hyperactivity Disorder
por: Galvez-Contreras, Alma Y., et al.
Publicado: (2017)

Can biomarkers be used to diagnose attention deficit hyperactivity disorder?
por: Chen, Hui, et al.
Publicado: (2023)

Responsivity of the Striatal Dopamine System to Methylphenidate—A Within-Subject I-123-β-CIT-SPECT Study in Male Children and Adolescents With Attention-Deficit/Hyperactivity Disorder
por: Aster, Hans-Christoph, et al.
Publicado: (2022)

Leg Movement Activity During Sleep in Adults With Attention-Deficit/Hyperactivity Disorder
por: Garbazza, Corrado, et al.
Publicado: (2018)

The Cochrane Collaboration withdraws a review on methylphenidate for adults with attention deficit hyperactivity disorder
por: Boesen, Kim, et al.
Publicado: (2017)

Methylphenidate improves response inhibition but not reflection–impulsivity in children with attention deficit hyperactivity disorder (ADHD)
por: DeVito, Elise E., et al.
Publicado: (2008)

Functional improvement and correlations with symptomatic improvement in adults with attention deficit hyperactivity disorder receiving long-acting methylphenidate
por: Buitelaar, J. K., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_i86agc22kfrhv5nnnm0teiprj9